<DOC>
	<DOCNO>NCT00317733</DOCNO>
	<brief_summary>The purpose study determine safety effectiveness 110 mg ketoprofen Transfersome apply skin twice daily compare placebo oral celecoxib 200 mg per day relief sign symptom osteoarthritis knee period six week .</brief_summary>
	<brief_title>Ketoprofen Transfersome Compared Oral Celecoxib Placebo Pain Associated With Osteoarthritis Knee</brief_title>
	<detailed_description>This multicenter , randomize ( patient assign different treatment base chance ) , double-blind ( neither patient physician know whether drug placebo take , dosage ) , double-dummy , parallel group , placebo- active-controlled study determine safety effectiveness 110 mg ketoprofen Transfersome , apply skin , subject experience least moderate pain take analgesic medication secondary osteoarthritis pain knee . The study hypothesis ketoprofen Transfersome apply skin twice daily effective placebo relief sign symptom osteoarthritis knee measure Visual Analog Scale ( VAS ) Western Ontario McMaster Universities Index ( WOMAC ) pain , WOMAC function subject global asessment response therapy Week 6 . WOMAC questionaire consist 24 question design assess three dimension pain , disability joint stiffness osteoarthritis knee . Safety evaluation include report adverse event , laboratory test skin irritation . Patients receive one follow treatment six week - 110 mg ketoprofen Transfersome apply skin twice per day plus one placebo capsule administer orally twice per day , 100 mg celecoxib administer orally twice per day plus placebo Transfersome apply skin twice per day , Placebo Transfersome apply skin twice per day plus one placebo capsule administer orally twice twice per day .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Ketoprofen</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Osteoarthritis knee minimum six month Patient´s rating pain index knee take oral NSAIDs least 3 use 5point Likert scale Presenting two three follow criterion Morning stiffness le 30 minute duration , Crepitus motion , Age &gt; = 40 year Patients must use oral NSAIDs least 3 day per week 3 month prior screen patient take NSAID regular basis ( &gt; 25 30 day ) therapeutic level least 30 day prior screen Each follow three criterion ( osteoarthritis flare criterion ) must meet Index knee pain assessment walking least 40 mm VAS baseline , Increase index knee pain walk least 15 mm VAS baseline compare screening , Physician´s global assessment osteoarthritis 35 least 1 grade increase screen Grade 1 Grade 4 severity index knee base Kellgren Lawrence radiographic criterion Intraarticular injection arthroscopy index knee within 3 month prior screen Signs clinically important inflammation index knee include redness , warmth large bulge effusion loss normal contour Crystallineinduced synovitis index knee History , physical examination radiographic suggestive acute inflammatory arthritis , rheumatoid arthritis , psoriatic arthritis , septic arthritis , gout , pseudogout , fibromyalgia , lupus erythematosus , type inflammatory arthritis index knee</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Ketoprofen</keyword>
	<keyword>Transfersome</keyword>
	<keyword>Osteoarthritis , Knee</keyword>
</DOC>